Pathalys Pharma

Proteon Therapeutics

This company develops pharmaceuticals to improve blood flow and vascular access for patients with kidney and vascular diseases.

Sanifit

This biopharmaceutical company develops treatments for progressive vascular calcification disorders in patients with end-stage kidney disease.

Amolyt Pharma

This clinical-stage biopharmaceutical company develops therapeutic peptides to treat patients with rare endocrine and related diseases, including hypoparathyroidism and acromegaly.

Thrasos

This biotherapeutics company develops targeted peptide therapies for the prevention and treatment of kidney diseases for patients with acute and chronic renal conditions.

OxThera AB

This biopharmaceutical company develops bacteria-based therapies to treat patients with primary hyperoxaluria and other rare kidney diseases.

River Renal

This clinical-stage biotechnology company develops novel pharmaceutical therapies targeting orphan renal diseases for patients with unmet medical needs.

Chinook Therapeutics

This biopharmaceutical company develops precision medicines for patients with rare and severe chronic kidney diseases.

Mineralys

This biopharmaceutical company develops aldosterone synthase inhibitors to treat patients with uncontrolled hypertension and related cardio-renal-metabolic diseases.